Henrijette Richter

Examiner
DISC Type : cs

Board Member at Mozart Therapeutics, Inc

Copenhagen, Capital Region of Denmark, Denmark

Overview

Henrijette Richter is a Managing Partner at Sofinnova Partners, where she specializes in early-stage biotech and medtech investments. A scientist by training, she holds a Ph. D. in Molecular Biology from the University of Copenhagen and completed a postdoctoral fellowship at MIT. Before Sofinnova, she was instrumental in founding and building the venture firm Novo Seeds.

Henrijette transitioned from academic research to venture capital after observing the high-stress environment at MIT was not for her. She advocates for finding a career that brings happiness and keeping options open. She is a mother and has spoken about the importance of maintaining her individual identity while balancing work and family life.

Early in her venture capital career, she faced a crisis of confidence, feeling she didnt understand the financial discussions, and almost returned to science before persevering.

Personality Overview

Late Adopter

Overcautious

Unexpressive

They do not like taking risks at all and go for proven options in the end.  The only way to convince them is by showing them examples and ample proof. They are heavily focused on quality and prefer doing things the right way, even if it takes time.

Topics They Care About

Early-Stage Investing
Her role is focused on Sofinnova's flagship fund for early-stage investments in biotech and medtech, guiding companies from their initial phases.
Therapeutics Development
She holds board seats at multiple therapeutics companies, including Mozart Therapeutics and Nitrase Therapeutics, reflecting her focus on developing novel treatments.
AI in Healthcare
A speaker at the EUCVC Summit, she discusses how AI and deep tech are shaping the future of health innovation and transforming patient care.

Media Appearances

Henrijette has no verified media appearances

Work History

9-2021
Board Member at Mozart Therapeutics, Inc
7-2021
Board Member at Muna Therapeutics
4-2020
Board Member at Nitrase Therapeutics
9-2019
Board Member at Twentyeight-Seven Therapeutics
9-2019
Member of The Supervisory Board at iOmx Therapeutics AG

Education

2008 - 2008
executive course from Harvard Business School
2005 - 2006
Executive Certificate from Copenhagen Business School

More Information

Social Presence :

Prographics :

Exp : 18 Location : Copenhagen, Capital Region of Denmark, Denmark Job Level : N/A Designation : Board Member at Mozart Therapeutics, Inc
URL has been copied!

Insights For Selling To Henrijette

During A Call Or A Meeting

DO's

  • Be firm in your communication and stay in control
  • Expect them to be vague in response to your questions, ask firmly and pointedly
  • Ask them which other stakeholders would be important for this purchase decision

DONT's

  • Don't use phrases like 'do not worry', 'i promise' etc.
  • Don't rely on relationship building even if they act pleasantly
  • Avoid getting into storytelling mode, especially when they ask specific questions

When Cold Calling

When Writing An Email

While Negotiating & Closing

    The secret to closing fast with Henrijette is

  • Low-risk, adoption by others are very important to them, followed by confidence in ROI.
  • Will you ever get a clear answer from Henrijette

  • They are unlikely to say no, it's better to stop yourself once you have exhausted all the options.

Insights For Deal Planning

    How fast (or slow) will Henrijette move?

  • They do not like to rush and therefore can be quite slow in their decision-making.
  • Can Henrijette take some risk or not?

  • They have little risk-appetite and prefer to take measured decisions.

You And Henrijette

Personality Compatibility


More Profiles

Discover additional public profiles from our index.

Search more profiles

Looking for someone else? Search here for anyone.

Or visit Humantic AI to know more.